Michael Kraut MD

Oncology•Southfield, MI

Medical Director, Providence Cancer Institute

Join to View Full Profile

22301 Foster Winter Dr200Southfield, MI 48075
Phone+1 248-552-0620
Fax+1 248-552-0286

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1981 - 1983
Wayne State University School of MedicineResidency, Internal Medicine, 1978 - 1981
Wayne State University School of MedicineClass of 1978

Certifications & Licensure

MI State Medical License 1979 - 2024
IL State Medical License 1982 - 1987
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer Start of enrollment: 2004 Nov 01
Unknown status
Phase 2
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2013 Oct 14
Completed
Phase 2
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Jul 08
Completed
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

9 citations
Molecular imaging of the serotonin transporter availability and occupancy by antidepressant treatment in late-life depression
Gwenn S. Smith, Hiroto Kuwabara, Neda F Gould, Najilla Nassery, Alena Savonenko
Neuropharmacology. 2021-08-15
14 citations
Molecular imaging of beta-amyloid deposition in late-life depression.
Gwenn S. Smith, Hiroto Kuwabara, Ayon Nandi, Neda F Gould, Najilla Nassery
Neurobiology of Aging. 2021-01-15
5 citations
Gulf War illness associated with abnormal auditory P1 event-related potential: Evidence of impaired cholinergic processing replicated in a national sample.
Gail D. Tillman, Jeffrey S. Spence, Richard W. Briggs, Robert W. Haley, John Hart
Psychiatry Research. Neuroimaging. 2019-01-30